4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-054709
CFO & Executive Vice President acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dier Mardi · CFO & Executive Vice President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-12 | Grant or award : show line 1 in the form | +40,000 | 40,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-10-12 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +40,000 | $95.50 | 2030-10-12 | 40,000 | 40,000 | D |
Loading xslF345X03/doc4.xml…